[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.90.95. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 55
Citations 0
Observation
November 30, 2016

Topical Diphencyprone Immunotherapy for Painful Nodular Acral Recurrence of Kaposi Sarcoma

Author Affiliations
  • 1Section of Dermatology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy
  • 2Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
  • 3Istituto Dermopatico dell’Immacolata IRCCS, Rome, Italy
JAMA Dermatol. Published online November 30, 2016. doi:10.1001/jamadermatol.2016.4301

Goals of classic treatment of Kaposi sarcoma (KS) without visceral involvement are to control symptoms and improve function. Localized lesions are managed by surgical excision, cryotherapy, intralesional chemotherapy, or radiotherapy, which can be painful and are physician-applied treatments. Recently, less demanding treatments based on topical drugs have been proposed.14

First Page Preview View Large
First page PDF preview
First page PDF preview
×